Hesio

Hesio is an oral over‑the‑counter product that contains the flavonoids diosmin and hesperidin. Marketed in the European Union as a phlebotonic/vasoprotective agent, the preparation combines these compounds in a standardized ratio, although specific strength and dosage form are not disclosed. Hesio is intended to support venous health and capillary function, often as part of a broader plan for chronic venous insufficiency, hemorrhoids, or varicose veins.

Hesio is commonly employed to address conditions related to impaired venous return, capillary fragility, and associated discomfort.

- Chronic venous insufficiency, characterized by leg heaviness, swelling, skin changes, and ulceration. - Symptomatic relief of hemorrhoidal disease, including bleeding, pain, prolapse, and itching. - Management of varicose veins to reduce discomfort, edema, and prevent progression. - Support of microvascular health in patients with capillary hyperpermeability and inflammation. - Adjunctive therapy for peripheral circulatory disorders when combined with compression or lifestyle measures, and improve walking tolerance. - Prevention of recurrence of minor bleeding episodes in patients with chronic hemorrhoidal disease.

Adverse reactions to Hesio are generally mild, but rare serious events have been reported.

Common: - Gastrointestinal discomfort such as nausea, abdominal pain, or dyspepsia. - Headache or mild dizziness. - Transient skin flushing or warmth. - Mild insomnia or sleep disturbance. - Temporary increase in blood pressure readings. - Dry mouth or altered taste sensation. - Mild fatigue or feeling of weakness. - Transient visual disturbances such as blurred vision.

Serious: - Allergic reactions including rash, pruritus, or angio‑edema. - Severe gastrointestinal bleeding or ulceration. - Hepatic enzyme elevation or liver dysfunction. - Thrombotic events such as deep vein thrombosis (rare). - Renal impairment manifested by elevated creatinine. - Severe hypotension leading to dizziness or syncope. - Anaphylactic shock (extremely rare). - Cardiac arrhythmias reported in isolated cases.

When considering Hesio, several precautionary measures should be observed to minimize risk and ensure appropriate use.

- Assess for known hypersensitivity to diosmin, hesperidin, or related flavonoids before initiating therapy. - Use cautiously in patients with hepatic or renal impairment, adjusting duration as clinically indicated. - Monitor blood pressure periodically, especially in individuals with a history of hypertension or hypotension. - Avoid use during pregnancy or lactation unless the benefit outweighs potential risk, due to limited safety data. - Consider potential interactions with anticoagulants or antiplatelet agents and evaluate bleeding risk. - Discontinue if signs of severe allergic reaction or hepatic dysfunction appear. - Consult a healthcare professional before combining with other vasoprotective supplements.

Hesio may affect the activity of certain medicines; awareness of these interactions helps maintain therapeutic safety.

Avoid: - Concomitant use with high‑dose anticoagulants (e.g., warfarin, apixaban) due to increased bleeding risk. - Combination with potent antiplatelet agents (e.g., clopidogrel, aspirin) without medical supervision.

Use with caution: - Co‑administration with other flavonoid supplements may potentiate vasoprotective effects and cause additive side effects. - Concurrent use of diuretics may enhance hypotensive effects; monitor blood pressure. - Patients on hepatically metabolized drugs (e.g., statins, certain antihypertensives) should be observed for altered plasma levels. - NSAIDs may increase gastrointestinal irritation when taken together; consider gastro‑protective measures.